Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (40)
Umair Ali Khan Saddozai, Fengling Wang, Saadullah Khattak, Muhammad Usman Akbar, Muhammad Badar, Nazeer Hussain Khan, Lu Zhang, Wan Zhu, Longxiang Xie, Yongqiang Li, Xinying Ji & Xiangqian Guo. (2022) Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma. Cells 11:18, pages 2924.
Crossref
Crossref
Fatéméh Dubois, Céline Bazille, Jérôme Levallet, Elodie Maille, Solenn Brosseau, Jeannick Madelaine, Emmanuel Bergot, Gérard Zalcman & Guénaëlle Levallet. (2022) Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP. Targeted Oncology 17:4, pages 407-431.
Crossref
Crossref
Gaetano Pezzicoli, Mimma Rizzo, Martina Perrone, Silvia Minei, Luciano Mutti & Camillo Porta. (2021) A Glimpse in the Future of Malignant Mesothelioma Treatment. Frontiers in Pharmacology 12.
Crossref
Crossref
Ben Johnson, Kenneth Lee & Yuen Yee Cheng. (2021) Pre-Clinical Research Advancements Relating to Improving the Diagnosis and Treatment of Malignant Pleural Mesothelioma: A Review. Onco 1:2, pages 49-82.
Crossref
Crossref
Giovanni Cugliari, Alessandra Allione, Alessia Russo, Chiara Catalano, Elisabetta Casalone, Simonetta Guarrera, Federica Grosso, Daniela Ferrante, Marika Sculco, Marta La Vecchia, Chiara Pirazzini, Roberta Libener, Dario Mirabelli, Corrado Magnani, Irma Dianzani & Giuseppe Matullo. (2021) New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment. Cancers 13:11, pages 2636.
Crossref
Crossref
Melanie Vogl, Anna Rosenmayr, Tomas Bohanes, Axel Scheed, Milos Brndiar, Elisabeth Stubenberger & Bahil Ghanim. (2021) Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation. Cancers 13:4, pages 658.
Crossref
Crossref
Joman Javadi, Ghazal Heidari-Hamedani, Angelika Schmalzl, Tünde Szatmári, Muzaffer Metintas, Pontus Aspenström, Anders Hjerpe & Katalin Dobra. (2021) Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells. Cancers 13:4, pages 655.
Crossref
Crossref
Emily S. Reardon, Vivek Shukla, Sichuan Xi, Sudheer K. Gara, Yi Liu, David Straughan, Mary Zhang, Julie A. Hong, Eden C. Payabyab, Anju Kumari, William G. Richards, Assunta De Rienzo, Raffit Hassan, Markku Miettinen, Liqiang Xi, Mark Raffeld, Lisa T. Uechi, Xinmin Li, Ruihong Wang, Haobin Chen, Chuong D. Hoang, Raphael Bueno & David S. Schrump. (2021) UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology 16:1, pages 89-103.
Crossref
Crossref
Giovanni Cugliari, Chiara Catalano, Simonetta Guarrera, Alessandra Allione, Elisabetta Casalone, Alessia Russo, Federica Grosso, Daniela Ferrante, Clara Viberti, Anna Aspesi, Marika Sculco, Chiara Pirazzini, Roberta Libener, Dario Mirabelli, Corrado Magnani, Irma Dianzani & Giuseppe Matullo. (2020) DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma. Cancers 12:11, pages 3470.
Crossref
Crossref
Oana M. Voloaca, Calum J. Greenhalgh, Laura M. Cole, Malcolm R. Clench, Amy J. Managh & Sarah L. Haywood‐Small. (2020) Laser ablation inductively coupled plasma mass spectrometry as a novel clinical imaging tool to detect asbestos fibres in malignant mesothelioma. Rapid Communications in Mass Spectrometry 34:21.
Crossref
Crossref
Calum J. Greenhalgh, Oana M. Voloaca, Phil Shaw, Ariane Donard, Laura M. Cole, Malcolm R. Clench, Amy J. Managh & Sarah L. Haywood-Small. (2020) Needles in haystacks: using fast-response LA chambers and ICP-TOF-MS to identify asbestos fibres in malignant mesothelioma models. Journal of Analytical Atomic Spectrometry 35:10, pages 2231-2238.
Crossref
Crossref
Manav Gandhi & Sujit Nair. (2020) New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction. Life Sciences 257, pages 118123.
Crossref
Crossref
María Cámara-Quílez, Aida Barreiro-Alonso, Ángel Vizoso-Vázquez, Esther Rodríguez-Belmonte, María Quindós-Varela, Mónica Lamas-Maceiras & María Esperanza Cerdán. (2020) The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response. Cancers 12:9, pages 2435.
Crossref
Crossref
Marcella Barbarino, Daniele Cesari, Maria Bottaro, Luca Luzzi, Asadoor Namagerdi, Franca Maria Bertolino, Cristiana Bellan, Fabrizio Proietti, Pasquale Somma, Mariacarolina Micheli, Maria Margherita Santi, Raffaella Guazzo, Luciano Mutti, Luigi Pirtoli, Piero Paladini, Paola Indovina & Antonio Giordano. (2020)
PRMT5 silencing selectively affects
MTAP
‐deleted mesothelioma: In vitro evidence of a novel promising approach
. Journal of Cellular and Molecular Medicine 24:10, pages 5565-5577.
Crossref
Crossref
Shibo Ying, Yanbin Wang & Lyuyang Lyu. 2020. Asbestos-related Diseases. Asbestos-related Diseases.
Vita Dolzan & Alenka Franko. 2020. Diseases of Pleura. Diseases of Pleura.
Juliana Restrepo lópez, Nelson Buelvas Gómez, Uriel Ovidio Cardona Nuñez & Mauricio García Mora. (2019) Manejo del mesotelioma peritoneal maligno con citorreducción quirúrgica más quimioterapia hipertérmica intraperitoneal en el Instituto Nacional de Cancerología, Colombia: reporte de un caso y revisión bibliográfica. Revista Colombiana de Cirugía 34:3, pages 292-299.
Crossref
Crossref
Marta Betti, Anna Aspesi, Marika Sculco, Giuseppe Matullo, Corrado Magnani & Irma Dianzani. (2019) Genetic predisposition for malignant mesothelioma: A concise review. Mutation Research/Reviews in Mutation Research 781, pages 1-10.
Crossref
Crossref
Li Zhang, Anand Singh, Christopher Plaisier, Nathanael Pruett, R. Taylor Ripley, David S. Schrump & Chuong D. Hoang. (2019) Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-κB-Mediated Signaling. Translational Oncology 12:6, pages 859-870.
Crossref
Crossref
Christelle Sépult, Marine Bellefroid, Natacha Rocks, Kim Donati, Catherine Gérard, Christine Gilles, Andreas Ludwig, Bernard Duysinx, Agnès Noël & Didier Cataldo. (2019) ADAM10 mediates malignant pleural mesothelioma invasiveness. Oncogene 38:18, pages 3521-3534.
Crossref
Crossref
Anne Tsao, Takashi Nakano, Anna K. Nowak, Sanjay Popat, Giorgio V. Scagliotti & John Heymach. (2019) Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma. Seminars in Oncology 46:2, pages 145-154.
Crossref
Crossref
Masayo Yoshimura, Yoshiaki Kinoshita, Makoto Hamasaki, Shinji Matsumoto, Tomoyuki Hida, Yoshinao Oda, Akinori Iwasaki & Kazuki Nabeshima. (2019) Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia. Lung Cancer 130, pages 187-193.
Crossref
Crossref
Yanbin Wang, Zhaoqiang Jiang, Jianing Yan & Shibo Ying. (2019) HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma. Disease Markers 2019, pages 1-10.
Crossref
Crossref
Zito Marino Federica, Sabetta Rosalaura, Ronchi Andrea, Marina Accardo, Italo Francesco Angelillo & Renato Franco. 2019. Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma
99
108
.
. 2019. Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma
57
90
.
Roberto G. Lucchini, Dana Hashim, Luca Lambertini & Donatella Placidi. 2019. Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma
1
13
.
Irina Zh. Zhubina, Irina O. Chikileva & Mikhail V. Kiselevskiy. 2019. Malignant Mesothelioma and Pseudomyxoma. Malignant Mesothelioma and Pseudomyxoma
101
120
.
Asuman Demiroglu-Zergeroglu, Nurettin Ayvali, Gulseren Turhal, Hurmuz Ceylan & Sultan Nacak Baytas. (2018)
Investigation of potent anticarcinogenic activity of 1, 3-diarylpyrazole acrylamide derivatives
in vitro
. Journal of Pharmacy and Pharmacology 70:12, pages 1619-1629.
Crossref
Crossref
Michele Carbone, Ivano Amelio, El Bachir Affar, James Brugarolas, Lisa A Cannon-Albright, Lewis C. Cantley, Webster K. Cavenee, Zhijian Chen, Carlo M. Croce, Alan D’ Andrea, David Gandara, Carlotta Giorgi, Wei Jia, Qing Lan, Tak Wah Mak, James L. Manley, Katsuhiko Mikoshiba, Jose N Onuchic, Harvey I. Pass, Paolo Pinton, Carol Prives, Nathaniel Rothman, Said M. Sebti, James Turkson, Xifeng Wu, Haining Yang, Herbert Yu & Gerry Melino. (2018) Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine. Cell Death & Differentiation 25:11, pages 1885-1904.
Crossref
Crossref
Uri Barash, Moshe Lapidot, Yaniv Zohar, Cynthia Loomis, Andre Moreira, Sari Feld, Chandra Goparaju, Haining Yang, Edward Hammond, Ganlin Zhang, Jin-Ping Li, Neta Ilan, Arnon Nagler, Harvey I Pass & Israel Vlodavsky. (2018) Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications. JNCI: Journal of the National Cancer Institute 110:10, pages 1102-1114.
Crossref
Crossref
Luciano Mutti, Tobias Peikert, Bruce W.S. Robinson, Arnaud Scherpereel, Anne S. Tsao, Marc de Perrot, Gavitt A. Woodard, David M. Jablons, Jacinta Wiens, Fred R. Hirsch, Haining Yang, Michele Carbone, Anish Thomas & Raffit Hassan. (2018) Scientific Advances and New Frontiers in Mesothelioma Therapeutics. Journal of Thoracic Oncology 13:9, pages 1269-1283.
Crossref
Crossref
Anand Singh, Richard Heery & Steven Gray. (2018) In Silico and In Vitro Analyses of LncRNAs as Potential Regulators in the Transition from the Epithelioid to Sarcomatoid Histotype of Malignant Pleural Mesothelioma (MPM). International Journal of Molecular Sciences 19:5, pages 1297.
Crossref
Crossref
Marika Rossini, Paola Rizzo, Ilaria Bononi, Anthony Clementz, Roberto Ferrari, Fernanda Martini & Mauro G. Tognon. (2018) New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma. Frontiers in Oncology 8.
Crossref
Crossref
L.M. Schunselaar, W. Zwart & P. Baas. (2017) Targeting BAP1: a new paradigm for mesothelioma. Lung Cancer 109, pages 145-146.
Crossref
Crossref
Zulfia McCroskey, Gregg Staerkel & Sinchita Roy-Chowdhuri. (2017) Utility of BRCA1-associated protein 1 immunoperoxidase stain to differentiate benign versus malignant mesothelial proliferations in cytologic specimens. Diagnostic Cytopathology 45:4, pages 312-319.
Crossref
Crossref
Sian Cregan, Maeve Breslin, Gerard Roche, Sigrid Wennstedt, Lauren MacDonagh, Cinaria Albadri, Yun Gao, Kenneth J. O'byrne, Sinead Cuffe, Stephen P. Finn & Steven G. Gray. (2017) Kdm6a and Kdm6b: Altered expression in malignant pleural mesothelioma. International Journal of Oncology 50:3, pages 1044-1052.
Crossref
Crossref
Shibo Ying, Zhaoqiang Jiang, Xianglei He, Min Yu, Riping Chen, Junqiang Chen, Guoqing Ru, Yuan Chen, Wanyuan Chen, Lijin Zhu, Tao Li, Yixiao Zhang, Xinnian Guo, Xianhong Yin, Xing Zhang & Jianlin Lou. (2017) Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. Disease Markers 2017, pages 1-9.
Crossref
Crossref
Andrea Napolitano & Michele Carbone. (2016) Malignant Mesothelioma: Time to Translate?. Trends in Cancer 2:9, pages 467-474.
Crossref
Crossref
Michele Carbone, Shreya Kanodia, Ann Chao, Aubrey Miller, Anil Wali, David Weissman, Alex Adjei, Francine Baumann, Paolo Boffetta, Brenda Buck, Marc de Perrot, A. Umran Dogan, Steve Gavett, Alessandro Gualtieri, Raffit Hassan, Mary Hesdorffer, Fred R. Hirsch, David Larson, Weimin Mao, Scott Masten, Harvey I. Pass, Julian Peto, Enrico Pira, Ian Steele, Anne Tsao, Gavitt Alida Woodard, Haining Yang & Shakun Malik. (2016) Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Journal of Thoracic Oncology 11:8, pages 1246-1262.
Crossref
Crossref
Mahadev Rao, Scott M. Atay, Vivek Shukla, Young Hong, Trevor Upham, R. Taylor Ripley, Julie A. Hong, Mary Zhang, Emily Reardon, Patricia Fetsch, Markku Miettinen, Xinmin Li, Cody J. Peer, Tristan Sissung, William D. Figg, Assunta De Rienzo, Raphael Bueno & David S. Schrump. (2016) Mithramycin Depletes Specificity Protein 1 and Activates p53 to Mediate Senescence and Apoptosis of Malignant Pleural Mesothelioma Cells. Clinical Cancer Research 22:5, pages 1197-1210.
Crossref
Crossref